
Keywords: AD, Alzheimer's disease; GOF, gain of function; LOF, loss of function; MoA, mode of action; TTD, Therapeutic Target Database; Aβ, amyloid-β; ROS, reactive oxygen species; ACE, angiotensin-converting enzyme; APP, amyloid-protein precursor; ACEi, ACE inhibi